MeSH term
Frequency | Condition_Probility | Humans | 494 | 0.0 |
Antigens/immunology | 4 | 2.0 |
Mutation | 17 | 0.0 |
Phosphorylation | 120 | 1.0 |
Receptors, Antigen, B-Cell/*physiology | 44 | 57.0 |
Research Support, Non-U.S. Gov't | 371 | 0.0 |
*Signal Transduction | 38 | 1.0 |
Tumor Cells, Cultured | 97 | 0.0 |
Tyrosine/metabolism | 39 | 3.0 |
Vanadates/pharmacology | 6 | 4.0 |
Alternative Splicing | 2 | 0.0 |
Cell Line | 93 | 0.0 |
Dimerization | 8 | 0.0 |
Immunoglobulin M/analysis | 3 | 1.0 |
Protein Biosynthesis | 6 | 0.0 |
Animals | 254 | 0.0 |
Chromosome Deletion | 4 | 0.0 |
Chromosome Mapping | 24 | 0.0 |
*Chromosomes, Human, Pair 22 | 23 | 10.0 |
*Chromosomes, Human, Pair 9 | 11 | 4.0 |
Evolution | 2 | 0.0 |
Fusion Proteins, bcr-abl/*genetics | 43 | 55.0 |
Genetic Markers | 5 | 0.0 |
In Situ Hybridization, Fluorescence | 17 | 0.0 |
Karyotyping | 22 | 1.0 |
Leukemia, Myeloid, Philadelphia-Positive/*genetics | 19 | 70.0 |
Male | 89 | 0.0 |
Middle Aged | 67 | 0.0 |
*Philadelphia Chromosome | 42 | 58.0 |
Reverse Transcriptase Polymerase Chain Reaction | 20 | 0.0 |
*Translocation, Genetic | 25 | 2.0 |
Glycogen Synthase Kinase 3 | 4 | 4.0 |
Glycogen Synthase Kinases | 3 | 5.0 |
Isoenzymes/physiology | 2 | 4.0 |
Mice | 149 | 0.0 |
Mice, Inbred C57BL | 21 | 0.0 |
Phospholipase C/physiology | 3 | 11.0 |
*Protein-Serine-Threonine Kinases | 9 | 1.0 |
Proto-Oncogene Proteins/physiology | 2 | 1.0 |
Receptors, Antigen, B-Cell/immunology/metabolism/*physiology | 5 | 83.0 |
Signal Transduction/immunology | 9 | 2.0 |
Transcription, Genetic/immunology | 2 | 2.0 |
Amino Acid Motifs | 10 | 1.0 |
Amino Acid Sequence | 79 | 0.0 |
Chromosome Breakage/*genetics | 7 | 13.0 |
Exons | 30 | 0.0 |
Leukemia, Myeloid, Chronic/genetics | 6 | 24.0 |
Molecular Sequence Data | 120 | 0.0 |
Molecular Weight | 11 | 0.0 |
Protein Structure, Tertiary | 9 | 0.0 |
RNA, Messenger/genetics | 12 | 0.0 |
Sequence Analysis | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 13 | 2.0 |
B-Lymphocytes/*immunology | 44 | 5.0 |
Calcium Signaling/physiology | 2 | 5.0 |
Carrier Proteins/*metabolism | 5 | 0.0 |
Phosphoproteins/*metabolism | 8 | 1.0 |
Phosphotyrosine/metabolism | 12 | 2.0 |
Protein-Tyrosine Kinase/deficiency/genetics/*metabolism | 4 | 30.0 |
Research Support, U.S. Gov't, P.H.S. | 202 | 0.0 |
Signal Transduction/*physiology | 10 | 0.0 |
*Alternative Splicing | 3 | 0.0 |
Introns | 7 | 0.0 |
Leukemia, Myeloid, Chronic/*genetics | 31 | 50.0 |
Oncogene Proteins/*genetics | 14 | 9.0 |
Polymerase Chain Reaction/methods | 6 | 0.0 |
*Polymorphism, Genetic | 6 | 0.0 |
*Protein-Tyrosine Kinase | 51 | 16.0 |
*Proto-Oncogene Proteins | 39 | 2.0 |
Antigens, CD19/metabolism | 6 | 25.0 |
Lymphocyte Activation | 37 | 1.0 |
Protein-Tyrosine Kinase/metabolism | 31 | 3.0 |
Aged | 35 | 0.0 |
Female | 83 | 0.0 |
*Inversion, Chromosome | 2 | 2.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Transcription, Genetic | 21 | 0.0 |
Down-Regulation | 7 | 0.0 |
Gene Expression Regulation | 13 | 0.0 |
Herpesvirus 4, Human/*physiology | 2 | 3.0 |
RNA, Messenger/biosynthesis | 6 | 0.0 |
Virus Latency | 2 | 3.0 |
Adult | 71 | 0.0 |
Child, Preschool | 16 | 0.0 |
RNA, Messenger | 5 | 1.0 |
1-Phosphatidylinositol 3-Kinase/physiology | 4 | 3.0 |
B-Lymphocytes/*physiology | 12 | 8.0 |
Calcium/metabolism | 35 | 2.0 |
Mice, Inbred CBA | 3 | 0.0 |
Protein-Tyrosine Kinase/*physiology | 7 | 5.0 |
Receptors, Antigen, B-Cell/physiology | 12 | 36.0 |
Antigens, CD/*immunology | 9 | 1.0 |
Antigens, Differentiation, B-Lymphocyte/*immunology | 3 | 4.0 |
Ligands | 16 | 0.0 |
NF-kappa B/physiology | 3 | 3.0 |
B-Lymphocytes/metabolism | 10 | 5.0 |
Blotting, Western | 16 | 0.0 |
Chickens | 30 | 4.0 |
Enzyme Activation/physiology | 4 | 2.0 |
Mitogen-Activated Protein Kinases/*metabolism | 4 | 0.0 |
Precipitin Tests | 15 | 0.0 |
Receptors, Antigen, B-Cell/*metabolism | 49 | 62.0 |
Signal Transduction/physiology | 5 | 0.0 |
Transfection | 50 | 0.0 |
rac1 GTP-Binding Protein/*metabolism | 2 | 2.0 |
Antibodies, Anti-Idiotypic/*pharmacology | 3 | 30.0 |
Antibodies, Monoclonal/immunology/pharmacology | 2 | 2.0 |
Antigens, CD/immunology/metabolism | 2 | 3.0 |
Antigens, Differentiation, B-Lymphocyte/immunology/metabolism | 2 | 22.0 |
Apoptosis/*drug effects | 4 | 0.0 |
*Cell Adhesion Molecules | 14 | 6.0 |
Flow Cytometry | 17 | 0.0 |
*Lectins | 13 | 7.0 |
Gene Expression | 18 | 0.0 |
Herpesvirus 4, Human/*metabolism | 2 | 4.0 |
Mice, Knockout | 20 | 0.0 |
Mice, Transgenic | 17 | 0.0 |
Phenotype | 11 | 0.0 |
Protein-Tyrosine Kinase/genetics/*metabolism | 8 | 5.0 |
B-Lymphocytes/cytology/drug effects/*immunology | 2 | 20.0 |
CD40 Ligand/pharmacology | 2 | 7.0 |
Receptors, Antigen, B-Cell/immunology/*metabolism | 6 | 54.0 |
T-Lymphocytes/cytology | 2 | 2.0 |
Tonsil/cytology | 3 | 3.0 |
Cell Differentiation | 18 | 0.0 |
Genes, Immunoglobulin | 3 | 1.0 |
Lymphocyte Activation/*immunology | 6 | 1.0 |
Macromolecular Substances | 19 | 0.0 |
Models, Immunological | 6 | 2.0 |
Receptors, Antigen, B-Cell/chemistry/*immunology | 2 | 100.0 |
Spleen/immunology | 5 | 2.0 |
VDJ Recombinases | 2 | 3.0 |
src-Family Kinases/physiology | 5 | 15.0 |
B-Lymphocytes/*metabolism | 21 | 10.0 |
Cell Division | 13 | 0.0 |
Cells, Cultured | 37 | 0.0 |
Enzyme Activation | 47 | 1.0 |
Enzyme Inhibitors/pharmacology | 16 | 0.0 |
Immunoblotting | 11 | 0.0 |
MAP Kinase Kinase 1 | 2 | 1.0 |
MAP Kinase Kinase 2 | 2 | 4.0 |
Mice, Inbred BALB C | 17 | 0.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 5 | 1.0 |
Mitogen-Activated Protein Kinase 3 | 4 | 0.0 |
Models, Biological | 20 | 0.0 |
Protein Binding | 19 | 0.0 |
Protein Kinase C/metabolism | 3 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 3 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 31 | 3.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Signal Transduction | 90 | 1.0 |
Spleen/metabolism | 3 | 2.0 |
B-Lymphocytes/cytology/*immunology | 8 | 11.0 |
Cell Differentiation/immunology | 10 | 3.0 |
Lymphocyte Activation/immunology | 3 | 0.0 |
Receptors, Antigen, B-Cell | 2 | 50.0 |
Signal Transduction/*immunology | 29 | 7.0 |
Antibody Specificity | 5 | 0.0 |
COS Cells | 6 | 0.0 |
K562 Cells | 6 | 1.0 |
Structure-Activity Relationship | 7 | 0.0 |
Calcium/immunology | 2 | 20.0 |
*Cell Cycle Proteins | 8 | 0.0 |
Receptors, Antigen, B-Cell/genetics/*immunology | 3 | 75.0 |
Signal Transduction/genetics/*immunology | 8 | 9.0 |
*Adaptor Proteins, Signal Transducing | 31 | 2.0 |
B-Lymphocytes/*immunology/*metabolism | 5 | 29.0 |
Calcium Signaling/*physiology | 2 | 4.0 |
Membrane Proteins/genetics/*metabolism | 2 | 0.0 |
Mice, SCID | 3 | 0.0 |
Sequence Homology, Amino Acid | 15 | 0.0 |
src-Family Kinases/metabolism | 18 | 9.0 |
Cell Differentiation/genetics/immunology | 3 | 3.0 |
Signal Transduction/genetics/immunology | 3 | 3.0 |
Cell Membrane/immunology | 4 | 1.0 |
Hela Cells | 6 | 0.0 |
Hematopoietic Stem Cells/cytology/immunology | 3 | 9.0 |
Recombinant Fusion Proteins/genetics/immunology | 2 | 4.0 |
Aged, 80 and over | 12 | 0.0 |
Child | 20 | 0.0 |
Chromosome Breakage/genetics | 3 | 4.0 |
Interphase/*genetics | 2 | 25.0 |
Leukemia, Myeloid/*genetics/pathology | 2 | 7.0 |
Translocation, Genetic/*genetics | 10 | 4.0 |
Base Sequence | 85 | 0.0 |
Chromosomes, Human, Pair 22/*genetics | 5 | 5.0 |
Genes, abl/*genetics | 6 | 35.0 |
Myeloproliferative Disorders/*genetics | 3 | 10.0 |
Oncogene Proteins, Fusion/*genetics | 3 | 1.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors | 2 | 2.0 |
*Chromosomes, Human, Pair 8 | 2 | 0.0 |
Fusion Proteins, bcr-abl/genetics | 10 | 24.0 |
Leukemia, Myeloid, Chronic/*genetics/pathology | 3 | 18.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors | 4 | 1.0 |
RNA, Messenger/analysis | 13 | 0.0 |
Blotting, Northern | 10 | 0.0 |
DNA, Complementary/metabolism | 5 | 0.0 |
Gene Deletion | 2 | 0.0 |
Immunoglobulin M/immunology | 11 | 8.0 |
Plasmids/metabolism | 5 | 0.0 |
Promoter Regions (Genetics) | 10 | 0.0 |
Protein-Tyrosine Kinase/*chemistry/*metabolism | 3 | 20.0 |
Proto-Oncogene Proteins c-bcl-2/genetics | 2 | 1.0 |
Receptors, Antigen, B-Cell/metabolism | 24 | 48.0 |
Tissue Distribution | 3 | 0.0 |
Antigens, CD/*metabolism | 11 | 1.0 |
Calcium/*metabolism | 9 | 1.0 |
*Membrane Proteins | 5 | 0.0 |
Phosphoric Monoester Hydrolases/*metabolism | 10 | 10.0 |
Receptors, IgG/*metabolism | 5 | 8.0 |
Time Factors | 17 | 0.0 |
Antigens, CD/genetics/metabolism | 3 | 5.0 |
Mitogen-Activated Protein Kinases/metabolism | 13 | 1.0 |
Phosphotyrosine/*metabolism | 2 | 3.0 |
Protein-Tyrosine-Phosphatase/*metabolism | 7 | 5.0 |
Receptors, IgG/genetics/metabolism | 2 | 33.0 |
Receptors, Immunologic/genetics/*metabolism | 2 | 5.0 |
*src Homology Domains | 7 | 3.0 |
*Calcium Signaling | 2 | 4.0 |
Phosphoric Monoester Hydrolases/physiology | 2 | 15.0 |
Receptors, IgG/*physiology | 3 | 10.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 14 | 0.0 |
Antigens, CD/metabolism | 10 | 1.0 |
Antigens, Differentiation, B-Lymphocyte/metabolism | 3 | 5.0 |
B-Lymphocytes/enzymology/immunology | 2 | 15.0 |
Protein-Tyrosine-Phosphatase/metabolism | 5 | 4.0 |
1-Phosphatidylinositol 3-Kinase/genetics/*metabolism | 2 | 13.0 |
Androstadienes/pharmacology | 3 | 1.0 |
Cyclosporine/pharmacology | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 9 | 0.0 |
*Gene Expression Regulation | 4 | 0.0 |
Genes, Reporter | 5 | 0.0 |
*Nuclear Proteins | 6 | 0.0 |
Recombinant Fusion Proteins/metabolism | 7 | 0.0 |
Transcription Factors/metabolism | 7 | 0.0 |
*Transcription, Genetic | 8 | 0.0 |
Up-Regulation | 2 | 0.0 |
*Fusion Proteins, bcr-abl | 2 | 100.0 |
*Sequence Deletion | 2 | 0.0 |
Antigens, CD/*physiology | 4 | 1.0 |
Lipids/*metabolism | 2 | 0.0 |
Phosphoric Monoester Hydrolases/*physiology | 2 | 6.0 |
Protein Transport | 4 | 0.0 |
CHO Cells | 3 | 0.0 |
Enzyme Activation/drug effects | 4 | 0.0 |
Hamsters | 4 | 0.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 2 | 1.0 |
Oncogene Proteins/genetics/*metabolism | 3 | 6.0 |
Rats | 20 | 0.0 |
Signal Transduction/drug effects/physiology | 2 | 0.0 |
ras Proteins/metabolism | 4 | 2.0 |
Antigens, Differentiation, B-Lymphocyte/*physiology | 2 | 5.0 |
DNA Primers | 7 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 6 | 1.0 |
Proteins/*metabolism | 9 | 1.0 |
Alu Elements/*genetics | 2 | 6.0 |
Comparative Study | 35 | 0.0 |
Signal Transduction/drug effects | 2 | 0.0 |
*beta-Cyclodextrins | 2 | 4.0 |
GTP Phosphohydrolases/*metabolism | 5 | 4.0 |
In Vitro | 3 | 0.0 |
Membrane Proteins/metabolism | 3 | 0.0 |
Recombinant Proteins/metabolism | 13 | 0.0 |
Binding Sites | 22 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Glutathione Transferase/metabolism | 3 | 0.0 |
Hydrolysis | 4 | 0.0 |
Bone Marrow/pathology | 5 | 1.0 |
Diagnosis, Differential | 4 | 0.0 |
Disease Progression | 2 | 0.0 |
Chromosome Fragility | 5 | 8.0 |
*Chromosomes, Human, Pair 19 | 2 | 0.0 |
Chronic Disease | 5 | 0.0 |
Genome | 2 | 0.0 |
Leukemia, Myeloid/*genetics | 8 | 5.0 |
Enzyme Precursors/metabolism | 17 | 12.0 |
Isoenzymes/metabolism | 9 | 1.0 |
Phospholipase C/metabolism | 13 | 4.0 |
Carrier Proteins/*physiology | 3 | 1.0 |
*Adaptor Proteins, Vesicular Transport | 12 | 4.0 |
Phosphopeptides/metabolism | 3 | 10.0 |
Phosphoric Monoester Hydrolases/metabolism | 4 | 5.0 |
Proteins/metabolism | 15 | 1.0 |
Antibody Formation | 3 | 0.0 |
B-Lymphocytes/cytology/*enzymology | 3 | 60.0 |
*Lymphocyte Activation | 9 | 0.0 |
Mice, Mutant Strains | 5 | 0.0 |
Protein Processing, Post-Translational | 6 | 0.0 |
Receptors, Antigen, B-Cell/immunology | 10 | 41.0 |
X Chromosome/genetics | 2 | 1.0 |
Histocompatibility Antigens Class II/immunology | 2 | 1.0 |
Receptors, Complement 3d/immunology | 3 | 16.0 |
Enzyme Activation/immunology | 11 | 8.0 |
MAP Kinase Signaling System/immunology | 2 | 10.0 |
Receptors, Antigen, B-Cell/*metabolism/physiology | 4 | 100.0 |
src Homology Domains/immunology | 4 | 14.0 |
Cell Line, Transformed | 10 | 0.0 |
Immunoglobulin M/*immunology | 6 | 9.0 |
src-Family Kinases/*metabolism | 5 | 3.0 |
Cell Membrane/metabolism | 6 | 0.0 |
Cross-Linking Reagents/pharmacology | 2 | 1.0 |
Cytochalasin D/pharmacology | 2 | 2.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Microscopy, Fluorescence | 5 | 0.0 |
DNA Mutational Analysis | 7 | 0.0 |
Introns/*genetics | 2 | 1.0 |
Leukemia, Myeloid, Chronic/diagnosis/*genetics | 5 | 83.0 |
RNA, Messenger/*genetics | 2 | 0.0 |
Antigens/*metabolism | 2 | 10.0 |
Cell Compartmentation/immunology | 2 | 40.0 |
Endocytosis/*immunology | 2 | 22.0 |
Kinetics | 24 | 0.0 |
Peptide Fragments/biosynthesis/immunology | 2 | 66.0 |
Protein Transport/immunology | 3 | 17.0 |
Subcellular Fractions/immunology/metabolism | 2 | 25.0 |
B-Lymphocytes/virology | 2 | 15.0 |
*Gene Expression Regulation, Viral | 2 | 0.0 |
Ubiquitin-Protein Ligases | 2 | 0.0 |
Substrate Specificity | 9 | 0.0 |
English Abstract | 18 | 0.0 |
Interferon-alpha/therapeutic use | 3 | 7.0 |
Binding Sites/genetics | 2 | 0.0 |
PC12 Cells | 2 | 0.0 |
Protein Structure, Tertiary/genetics | 2 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 11 | 1.0 |
*Oncogenes | 14 | 3.0 |
Serine/metabolism | 4 | 1.0 |
Antibodies, Anti-Idiotypic/immunology | 3 | 7.0 |
Cell Transformation, Neoplastic | 6 | 1.0 |
Proto-Oncogene Proteins c-myc/*physiology | 2 | 5.0 |
*Transcription Factors | 9 | 0.0 |
*Tumor Suppressor Proteins | 2 | 0.0 |
Cattle | 3 | 0.0 |
Cell Membrane/enzymology | 2 | 0.0 |
*Guanine Nucleotide Exchange Factors | 3 | 3.0 |
Nuclear Proteins/metabolism | 4 | 0.0 |
Phosphoproteins/metabolism | 14 | 2.0 |
Protein Isoprenylation | 2 | 2.0 |
ras GTPase-Activating Proteins/*metabolism | 2 | 33.0 |
Antigens, CD19/immunology | 4 | 10.0 |
Biological Transport | 8 | 0.0 |
Herpesvirus 4, Human/immunology | 2 | 2.0 |
Receptors, Antigen, B-Cell/*immunology | 19 | 51.0 |
*Apoptosis | 10 | 0.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Membrane Potentials | 4 | 1.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Phosphoproteins/*physiology | 2 | 2.0 |
T-Lymphocytes/immunology | 7 | 0.0 |
Autoradiography | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 4 | 0.0 |
Nucleic Acid Hybridization | 15 | 0.0 |
Actins/metabolism | 2 | 0.0 |
Immunoglobulins, mu-Chain/genetics | 2 | 14.0 |
Mutagenesis, Site-Directed | 12 | 0.0 |
Receptors, IgG/metabolism | 7 | 9.0 |
Temperature | 2 | 0.0 |
Recombination, Genetic | 8 | 0.0 |
Enzyme Precursors/*physiology | 3 | 20.0 |
Apoptosis/genetics | 2 | 0.0 |
*Exons | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 6 | 2.0 |
Immunoglobulins, Surface/metabolism | 3 | 15.0 |
Protein Binding/immunology | 8 | 4.0 |
Apoptosis/genetics/immunology | 3 | 37.0 |
B-Lymphocyte Subsets/cytology/*immunology/*metabolism | 2 | 33.0 |
Crosses, Genetic | 3 | 0.0 |
Immunophenotyping | 5 | 0.0 |
Ionophores/pharmacology | 2 | 1.0 |
Receptors, Antigen, B-Cell/metabolism/physiology | 5 | 71.0 |
Antigen Presentation/*immunology | 2 | 2.0 |
Cross-Linking Reagents | 15 | 4.0 |
Herpesvirus 4, Human/*immunology | 2 | 2.0 |
Receptors, Antigen, B-Cell/*immunology/metabolism | 2 | 50.0 |
B-Lymphocytes/enzymology/metabolism | 2 | 22.0 |
Catalysis | 2 | 0.0 |
Green Fluorescent Proteins | 3 | 0.0 |
src-Family Kinases/deficiency/genetics/*physiology | 2 | 100.0 |
*DNA-Binding Proteins | 3 | 0.0 |
Phosphoproteins/genetics/*metabolism | 3 | 1.0 |
Rabbits | 6 | 0.0 |
Antigens, CD/physiology | 4 | 1.0 |
Antigens, CD40/physiology | 4 | 13.0 |
Antigens, Differentiation, B-Lymphocyte/physiology | 2 | 10.0 |
Apoptosis | 15 | 0.0 |
src Homology Domains | 21 | 3.0 |
Bone Marrow Transplantation | 4 | 1.0 |
Gene Expression Profiling | 4 | 0.0 |
*Gene Rearrangement | 14 | 5.0 |
Recurrence | 4 | 0.0 |
Solubility | 2 | 0.0 |
Up-Regulation/genetics/immunology | 2 | 3.0 |
Acute Disease | 8 | 0.0 |
Alleles | 5 | 0.0 |
DNA, Complementary/genetics | 8 | 0.0 |
Exons/*genetics | 2 | 0.0 |
Fusion Proteins, bcr-abl/analysis/*genetics | 3 | 75.0 |
Leukemia, Myeloid, Philadelphia-Positive/genetics | 9 | 60.0 |
Myeloproliferative Disorders/genetics | 2 | 28.0 |
Oligonucleotide Probes | 4 | 0.0 |
Proto-Oncogene Proteins/*genetics | 12 | 1.0 |
Reference Values | 3 | 0.0 |
Apoptosis/*physiology | 6 | 0.0 |
src-Family Kinases/*physiology | 3 | 7.0 |
Leukemia, Lymphocytic, Acute, L2/*genetics | 3 | 27.0 |
Enzyme Precursors/genetics/*metabolism | 6 | 35.0 |
src-Family Kinases/genetics/*metabolism | 2 | 9.0 |
Burkitt Lymphoma/pathology | 3 | 9.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 3 | 0.0 |
Antigens, CD95/*metabolism | 2 | 1.0 |
Immunoglobulin D/metabolism | 2 | 22.0 |
Immunoglobulin M/metabolism | 5 | 6.0 |
B-Lymphocytes/*enzymology/*immunology | 2 | 50.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 7 | 2.0 |
Proto-Oncogene Proteins/metabolism | 7 | 0.0 |
B-Lymphocytes/cytology/*enzymology/*immunology | 2 | 100.0 |
Isoenzymes/*metabolism | 5 | 1.0 |
Phospholipase C/*metabolism | 8 | 7.0 |
B-Lymphocytes/*enzymology/immunology | 3 | 42.0 |
Calcium Signaling | 7 | 8.0 |
B-Lymphocytes/immunology | 6 | 0.0 |
Models, Molecular | 4 | 0.0 |
Protein Structure, Quaternary | 3 | 1.0 |
Lymphoma, B-Cell | 8 | 21.0 |
Antigens, CD40/*physiology | 2 | 5.0 |
B-Lymphocytes/immunology/*physiology | 7 | 43.0 |
Burkitt Lymphoma | 4 | 4.0 |
Tonsil/immunology | 2 | 3.0 |
Caspases/metabolism | 3 | 0.0 |
Antigens, CD19/genetics | 2 | 28.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Immunohistochemistry | 4 | 0.0 |
Protein Kinases/genetics | 3 | 5.0 |
Transcription Factors/genetics | 2 | 0.0 |
Cell Division/immunology | 6 | 2.0 |
Phosphoric Monoester Hydrolases/*immunology | 2 | 100.0 |
Carrier Proteins/genetics/*physiology | 2 | 2.0 |
Jurkat Cells | 4 | 0.0 |
Chromones/pharmacology | 3 | 1.0 |
Enzyme Activation/drug effects/immunology | 2 | 6.0 |
Morpholines/pharmacology | 3 | 1.0 |
Biological Transport/immunology | 2 | 7.0 |
Calcium Signaling/*immunology | 2 | 66.0 |
src Homology Domains/*immunology | 3 | 21.0 |
Antigens, CD/genetics/*metabolism | 3 | 3.0 |
Carrier Proteins/metabolism | 6 | 0.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Receptors, Antigen, B-Cell/genetics/*metabolism | 2 | 40.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Tyrosine/*metabolism | 17 | 5.0 |
Electrophoresis, Agar Gel | 3 | 0.0 |
Gene Fusion | 2 | 2.0 |
Receptors, IgG/physiology | 5 | 13.0 |
Species Specificity | 3 | 0.0 |
Cell Differentiation/*physiology | 2 | 0.0 |
Enzyme Precursors/physiology | 5 | 35.0 |
Immune Tolerance | 3 | 1.0 |
Immunoglobulins, Heavy-Chain/genetics | 3 | 1.0 |
Cell Line, Tumor | 6 | 0.0 |
Mutagenesis | 3 | 0.0 |
src Homology Domains/genetics | 2 | 3.0 |
Immunologic Capping | 4 | 8.0 |
B-Lymphocytes/*immunology/metabolism | 4 | 8.0 |
Cloning, Molecular | 28 | 0.0 |
DNA Primers/genetics | 4 | 0.0 |
Histocompatibility Antigens Class II/*immunology | 2 | 1.0 |
Infant | 8 | 0.0 |
Infant, Newborn | 4 | 0.0 |
*Proto-Oncogenes | 15 | 2.0 |
Antigens, Differentiation, B-Lymphocyte/genetics/*metabolism | 2 | 28.0 |
Glycosylation | 2 | 0.0 |
Lymphocytes/*metabolism | 2 | 1.0 |
Pregnancy | 2 | 0.0 |
Subcellular Fractions/metabolism | 3 | 0.0 |
T-Lymphocytes/metabolism | 2 | 0.0 |
U937 Cells | 2 | 0.0 |
Phosphoric Monoester Hydrolases/*chemistry/metabolism | 2 | 28.0 |
Recombinant Fusion Proteins/chemistry/metabolism | 2 | 1.0 |
Antigens, CD5/analysis | 2 | 4.0 |
Lymph Nodes/pathology | 2 | 0.0 |
Bone Marrow/metabolism | 2 | 1.0 |
Sensitivity and Specificity | 3 | 0.0 |
Isoenzymes/genetics/*metabolism | 2 | 2.0 |
Phospholipase C/genetics/*metabolism | 3 | 25.0 |
*Chromosomes, Human, Pair 11 | 2 | 0.0 |
DNA, Complementary | 6 | 0.0 |
DNA-Binding Proteins/*genetics | 6 | 0.0 |
Leukemia, Myeloid, Chronic/*diagnosis/*genetics | 2 | 100.0 |
Gene Expression Regulation/immunology | 3 | 1.0 |
Down-Regulation/genetics/*immunology | 2 | 10.0 |
Mice, Inbred DBA | 2 | 0.0 |
Fusion Proteins, bcr-abl/chemistry/*genetics | 3 | 75.0 |
Repetitive Sequences, Nucleic Acid | 3 | 0.0 |
Antigens, CD95/physiology | 3 | 4.0 |
Antigens, CD5/*metabolism | 2 | 9.0 |
Chimeric Proteins/metabolism | 2 | 1.0 |
Antineoplastic Agents/therapeutic use | 4 | 1.0 |
Fusion Proteins, bcr-abl/*metabolism | 2 | 5.0 |
Philadelphia Chromosome | 18 | 40.0 |
Polymerase Chain Reaction/*methods | 2 | 0.0 |
Polymorphism, Genetic | 4 | 0.0 |
RNA, Messenger/*metabolism | 4 | 0.0 |
Transplantation, Homologous | 2 | 0.0 |
Receptors, Antigen, B-Cell/immunology/*physiology | 3 | 100.0 |
Proteins/genetics/*metabolism | 2 | 0.0 |
Enzyme Precursors/*metabolism | 17 | 14.0 |
Phosphotyrosine | 4 | 1.0 |
Tyrosine | 3 | 2.0 |
*Ubiquitin-Protein Ligases | 4 | 0.0 |
3T3 Cells | 8 | 0.0 |
Binding, Competitive | 3 | 0.0 |
Phosphatidylinositol Phosphates/metabolism | 2 | 4.0 |
Protein-Tyrosine Kinase/*genetics | 2 | 0.0 |
Retroviridae Proteins, Oncogenic/metabolism | 2 | 5.0 |
Signal Transduction/genetics | 2 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 4 | 0.0 |
Models, Genetic | 5 | 0.0 |
Amino Acid Substitution | 3 | 0.0 |
Genes, Immediate-Early | 2 | 3.0 |
Immunoglobulins/blood | 2 | 2.0 |
Apoptosis/drug effects/*immunology | 2 | 5.0 |
Cell Survival | 5 | 0.0 |
Fusion Proteins, bcr-abl/*genetics/metabolism | 3 | 50.0 |
Leukemia, Lymphocytic, Acute/genetics | 5 | 16.0 |
Oligonucleotides, Antisense/pharmacology | 3 | 1.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 3 | 1.0 |
Protein-Tyrosine Kinase/physiology | 4 | 3.0 |
Inositol 1,4,5-Trisphosphate/biosynthesis | 2 | 9.0 |
*Phosphoproteins | 3 | 2.0 |
Receptors, IgG/genetics | 2 | 11.0 |
src Homology Domains/genetics/*immunology | 2 | 33.0 |
*Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Lymphoma, B-Cell/pathology | 3 | 15.0 |
Recombinant Fusion Proteins/physiology | 5 | 1.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
14-3-3 Proteins | 2 | 1.0 |
Protein-Tyrosine Kinase/genetics/metabolism | 2 | 2.0 |
*Tyrosine 3-Monooxygenase | 2 | 4.0 |
Baculoviridae/genetics | 2 | 1.0 |
DNA-Binding Proteins/*metabolism | 4 | 0.0 |
Glutathione Transferase/genetics | 2 | 0.0 |
Antigens, CD/metabolism/*physiology | 2 | 7.0 |
Protein-Tyrosine-Phosphatase/*physiology | 3 | 11.0 |
1-Phosphatidylinositol 3-Kinase/genetics/metabolism | 2 | 25.0 |
*Lymphocyte Activation/drug effects | 2 | 1.0 |
Microscopy, Confocal | 4 | 0.0 |
Electrophysiology | 2 | 0.0 |
Evoked Potentials | 2 | 3.0 |
Reflex | 3 | 16.0 |
Linkage (Genetics) | 3 | 0.0 |
Enzyme Precursors/immunology/*metabolism | 2 | 50.0 |
Protein-Tyrosine Kinase/immunology/*metabolism | 3 | 15.0 |
src-Family Kinases/immunology/*metabolism | 2 | 100.0 |
B-Lymphocytes/cytology/*immunology/metabolism | 3 | 30.0 |
GTP-Binding Proteins/metabolism | 3 | 1.0 |
Lipids/metabolism | 2 | 0.0 |
Receptors, Antigen, B-Cell/*genetics | 2 | 18.0 |
B-Lymphocytes/immunology/metabolism | 6 | 11.0 |
Inositol Phosphates/metabolism | 2 | 1.0 |
GTPase-Activating Proteins | 9 | 5.0 |
Proteins/*genetics | 3 | 0.0 |
ras GTPase-Activating Proteins | 4 | 3.0 |
Blotting, Southern | 34 | 1.0 |
Chromosome Breakage | 2 | 2.0 |
Reverse Transcriptase Polymerase Chain Reaction/methods | 3 | 0.0 |
B-Lymphocytes/immunology/pathology | 2 | 4.0 |
DNA-Binding Proteins/genetics/*physiology | 2 | 0.0 |
Protein Kinase C/*metabolism | 4 | 1.0 |
*Endocytosis | 2 | 1.0 |
Membrane Proteins/*metabolism | 4 | 0.0 |
Thapsigargin/pharmacology | 2 | 1.0 |
Spleen/cytology | 3 | 1.0 |
*Gene Expression Regulation, Leukemic | 3 | 3.0 |
Adolescent | 28 | 0.0 |
Antigens, CD/*genetics | 3 | 1.0 |
*Variation (Genetics) | 3 | 0.0 |
Antibodies, Monoclonal | 5 | 0.0 |
B-Lymphocytes/enzymology/*immunology | 3 | 50.0 |
RNA, Neoplasm/analysis | 5 | 1.0 |
GTP-Binding Proteins/*metabolism | 7 | 1.0 |
*Mitogen-Activated Protein Kinases | 4 | 1.0 |
rac GTP-Binding Proteins | 6 | 3.0 |
Receptor Protein-Tyrosine Kinases/*metabolism | 2 | 0.0 |
ras Proteins/*metabolism | 2 | 1.0 |
DNA, Neoplasm/genetics | 13 | 1.0 |
*Genes, Immunoglobulin | 2 | 1.0 |
Immunoglobulin Variable Region/genetics | 2 | 1.0 |
Polymerase Chain Reaction | 42 | 0.0 |
Receptors, Antigen, B-Cell/genetics | 2 | 40.0 |
*RNA Processing, Post-Transcriptional | 2 | 3.0 |
RNA Splicing | 9 | 1.0 |
CD40 Ligand | 2 | 1.0 |
Cell Division/drug effects | 6 | 0.0 |
Immunoglobulin G/biosynthesis | 2 | 1.0 |
Immunoglobulin M/biosynthesis | 2 | 2.0 |
Interleukin-2/pharmacology | 3 | 0.0 |
Blast Crisis | 3 | 8.0 |
Chromosome Aberrations | 5 | 0.0 |
Antibodies/pharmacology | 2 | 0.0 |
Cell Membrane/chemistry | 2 | 1.0 |
Receptors, Antigen, B-Cell/analysis/*metabolism | 2 | 100.0 |
RNA, Neoplasm/genetics | 5 | 1.0 |
*Carrier Proteins | 3 | 0.0 |
*Viral Proteins | 3 | 1.0 |
B-Lymphocytes/immunology/*metabolism | 7 | 12.0 |
Inositol 1,4,5-Trisphosphate/metabolism | 4 | 7.0 |
Chromosomes, Human, Pair 9/*genetics | 3 | 2.0 |
Leukemia, Myeloid, Philadelphia-Negative/*genetics | 5 | 62.0 |
Antigens, CD19/*metabolism | 3 | 18.0 |
Antigens, Differentiation, B-Lymphocyte/*metabolism | 3 | 8.0 |
Immunoglobulins, alpha-Chain/metabolism | 2 | 100.0 |
Cell Transformation, Neoplastic/genetics | 2 | 0.0 |
*Chromosome Aberrations | 10 | 1.0 |
Chromosomes, Human, Pair 11/*genetics/ultrastructure | 2 | 11.0 |
DNA Topoisomerases, Type II/*metabolism | 2 | 10.0 |
Leukemia/*genetics | 6 | 4.0 |
Translocation, Genetic | 28 | 3.0 |
Antibodies, Monoclonal/*pharmacology | 2 | 1.0 |
Antibody Affinity | 3 | 1.0 |
B-Lymphocytes/immunology/*pathology | 2 | 7.0 |
Ionomycin/pharmacology | 2 | 0.0 |
Isoenzymes/genetics/physiology | 2 | 14.0 |
Receptors, Antigen, T-Cell/*physiology | 3 | 1.0 |
Antigens, CD/*chemistry/*metabolism | 2 | 25.0 |
Diglycerides/metabolism | 2 | 4.0 |
Oncogene Proteins/metabolism | 3 | 3.0 |
T-Lymphocytes/physiology | 2 | 1.0 |
Genes, ras | 3 | 1.0 |
Mitogen-Activated Protein Kinase 1 | 2 | 1.0 |
Receptor Protein-Tyrosine Kinases/metabolism | 2 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 4 | 0.0 |
Antibodies, Anti-Idiotypic/pharmacology | 3 | 9.0 |
Antibodies, Monoclonal/pharmacology | 2 | 0.0 |
Antigens, CD95/biosynthesis | 2 | 6.0 |
Apoptosis/immunology | 3 | 3.0 |
Gene Expression Regulation/*immunology | 3 | 2.0 |
*Lymphocyte Activation/immunology | 2 | 33.0 |
Nuclear Proteins/biosynthesis | 2 | 4.0 |
*Proteins | 2 | 0.0 |
TNF Receptor-Associated Factor 1 | 2 | 1.0 |
Genes, abl | 13 | 38.0 |
Proto-Oncogene Proteins c-abl | 6 | 75.0 |
*Chromosome Mapping | 3 | 0.0 |
Chromosomes, Human, Pair 14/*genetics | 2 | 2.0 |
Multigene Family | 8 | 0.0 |
*Bone Marrow Transplantation | 6 | 1.0 |
*Virus Latency | 2 | 4.0 |
*Antigen Presentation | 3 | 1.0 |
Cytoplasm/immunology | 3 | 3.0 |
Protein-Tyrosine Kinase/metabolism/*physiology | 2 | 7.0 |
Receptors, Antigen, B-Cell/chemistry/*physiology | 2 | 100.0 |
Leukemia, Erythroblastic, Acute/*genetics | 2 | 18.0 |
Chromosome Banding | 10 | 1.0 |
Chromosomes, Human, Pair 17 | 2 | 0.0 |
Chromosomes, Human, Pair 22 | 19 | 12.0 |
Chromosomes, Human, Pair 8 | 2 | 1.0 |
Chromosomes, Human, Pair 9 | 12 | 7.0 |
Hydrogen Peroxide/pharmacology | 3 | 1.0 |
Treatment Outcome | 2 | 0.0 |
Receptors, Antigen, B-Cell/immunology/metabolism | 2 | 33.0 |
Lymphocyte Activation/drug effects | 2 | 0.0 |
Signal Transduction/*drug effects | 3 | 0.0 |
Phosphorylation/drug effects | 4 | 0.0 |
Signal Transduction/drug effects/*immunology | 2 | 5.0 |
Polymorphism, Restriction Fragment Length | 10 | 0.0 |
Annexin A5/metabolism | 2 | 2.0 |
Apoptosis/*immunology | 3 | 1.0 |
Cysteine Proteinase Inhibitors/pharmacology | 2 | 0.0 |
Antigens, CD45/*physiology | 2 | 16.0 |
Receptor Aggregation | 3 | 3.0 |
B-Lymphocytes | 3 | 1.0 |
Rats, Inbred Strains | 2 | 0.0 |
Cell Membrane/immunology/metabolism | 2 | 1.0 |
Escherichia coli/genetics | 2 | 0.0 |
Recombinant Proteins | 2 | 0.0 |
rhoA GTP-Binding Protein | 3 | 3.0 |
Cell Cycle Proteins/*metabolism | 2 | 0.0 |
Guanosine Triphosphate/metabolism | 4 | 1.0 |
cdc42 GTP-Binding Protein | 2 | 2.0 |
Blast Crisis/*genetics | 2 | 15.0 |
Fusion Proteins, bcr-abl/genetics/*metabolism | 3 | 30.0 |
Proto-Oncogene Proteins c-bcl-2/*metabolism | 2 | 0.0 |
*Up-Regulation | 3 | 1.0 |
Protein Conformation | 4 | 0.0 |
Sequence Alignment | 7 | 0.0 |
Staphylococcus aureus/immunology | 2 | 1.0 |
RNA, Messenger/genetics/metabolism | 4 | 0.0 |
Antigens, CD40/*immunology | 2 | 5.0 |
Promoter Regions (Genetics)/immunology | 2 | 2.0 |
Receptors, Antigen, B-Cell/metabolism/*physiology | 4 | 100.0 |
Tetradecanoylphorbol Acetate/pharmacology | 3 | 0.0 |
Cell Separation | 5 | 0.0 |
Liver/cytology/embryology/enzymology | 2 | 66.0 |
Proto-Oncogene Proteins c-bcl-2/metabolism | 3 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Predictive Value of Tests | 2 | 0.0 |
Oncogene Proteins/genetics | 3 | 4.0 |
*Linkage (Genetics) | 2 | 0.0 |
Cell Count | 2 | 0.0 |
Immunoglobulins, lambda-Chain/genetics | 2 | 14.0 |
Receptors, IgE/*physiology | 2 | 14.0 |
Chromosome Aberrations/genetics | 2 | 1.0 |
Chromosome Disorders | 5 | 1.0 |
Electromyography | 2 | 1.0 |
Reaction Time/physiology | 2 | 2.0 |
Fluorescent Antibody Technique | 3 | 0.0 |
Point Mutation | 2 | 0.0 |
Immunoglobulins, Surface/*metabolism | 2 | 50.0 |
Leukemia, Myeloid, Chronic/therapy | 2 | 14.0 |
RNA, Catalytic/chemistry/*metabolism | 2 | 66.0 |
Proteins/*physiology | 2 | 1.0 |
Son of Sevenless Proteins | 2 | 3.0 |
Chimera | 8 | 4.0 |
DNA, Neoplasm/analysis | 5 | 0.0 |
Hematopoietic Stem Cell Transplantation | 2 | 1.0 |
Lipopolysaccharides/pharmacology | 3 | 0.0 |
Phosphatidylinositols/metabolism | 2 | 1.0 |
Oncogene Proteins/*biosynthesis/genetics | 2 | 25.0 |
Peptide Mapping | 4 | 0.0 |
Antigens, CD40/pharmacology | 2 | 40.0 |
B-Lymphocyte Subsets/*immunology | 2 | 2.0 |
Interleukin-4/pharmacology | 3 | 0.0 |
Consensus Sequence | 2 | 0.0 |
Receptors, Antigen, B-Cell/*chemistry/*physiology | 2 | 100.0 |
*Genes, abl | 13 | 46.0 |
Chimeric Proteins/genetics | 2 | 3.0 |
RNA, Messenger/*analysis | 3 | 0.0 |
ADP-ribosyl Cyclase | 3 | 0.0 |
*Antigens, CD | 3 | 0.0 |
Antigens, Differentiation/*analysis | 2 | 1.0 |
N-Glycosyl Hydrolases/*analysis | 2 | 14.0 |
Oncogene Proteins/*metabolism | 5 | 5.0 |
Sequence Deletion | 3 | 0.0 |
*Escherichia coli Proteins | 2 | 0.0 |
Receptors, IgG/*immunology | 2 | 6.0 |
Recombinant Fusion Proteins/biosynthesis | 3 | 0.0 |
Prognosis | 8 | 0.0 |
Immunoglobulins, kappa-Chain/immunology | 2 | 22.0 |
Gene Rearrangement | 16 | 3.0 |
Platelet Count | 2 | 0.0 |
Transcription Factors/biosynthesis/*metabolism | 2 | 4.0 |
Calcium/physiology | 2 | 0.0 |
Mutagenesis, Insertional | 2 | 0.0 |
Immunoglobulin Isotypes | 2 | 12.0 |
Immunologic Memory | 2 | 0.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Membrane Microdomains/metabolism | 2 | 6.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
Escherichia coli | 2 | 0.0 |
Restriction Mapping | 19 | 0.0 |
Zinc Fingers | 2 | 0.0 |
Guanine Nucleotide Exchange Factors | 3 | 3.0 |
ras Guanine Nucleotide Exchange Factors | 3 | 5.0 |
Cell Transformation, Neoplastic/*genetics | 2 | 1.0 |
Mice, Nude | 3 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Myeloproliferative Disorders/*genetics/pathology | 2 | 33.0 |
Protein-Tyrosine-Phosphatase/genetics/*metabolism | 3 | 6.0 |
*Promoter Regions (Genetics) | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 10 | 0.0 |
B-Lymphocytes/*cytology | 2 | 3.0 |
Membrane Glycoproteins/*physiology | 2 | 0.0 |
Antigens, CD5/*physiology | 2 | 66.0 |
Genistein | 2 | 2.0 |
Isoflavones/pharmacology | 2 | 3.0 |
Interferon Type II/pharmacology | 2 | 0.0 |
*Chromosome Fragility | 2 | 1.0 |
Peptides/chemistry | 3 | 0.0 |
Cell Differentiation/physiology | 2 | 0.0 |
Clone Cells | 2 | 0.0 |
Oncogenes | 3 | 1.0 |
Endoplasmic Reticulum/metabolism | 3 | 1.0 |
Membrane Glycoproteins/*metabolism | 2 | 0.0 |
Chromosomes, Human, Pair 11 | 2 | 0.0 |
Bone Marrow/*pathology | 3 | 2.0 |
Leukemia, Myeloid, Philadelphia-Positive/genetics/*pathology | 5 | 55.0 |
Antibodies, Monoclonal/chemistry | 2 | 2.0 |
Intracellular Fluid/*immunology/*metabolism | 2 | 50.0 |
Gene Rearrangement/*genetics | 4 | 11.0 |
Proto-Oncogenes | 4 | 2.0 |
Survival Analysis | 2 | 0.0 |
*Genes, Structural | 2 | 0.0 |
Mice/genetics | 2 | 3.0 |
Tyrosine/analogs & derivatives/metabolism | 2 | 1.0 |
RNA, Messenger/analysis/genetics | 2 | 0.0 |
RNA, Neoplasm/analysis/genetics | 3 | 15.0 |
Chromosome Aberrations/*genetics | 3 | 2.0 |
Syndrome | 2 | 0.0 |
*src-Family Kinases | 2 | 4.0 |
Neoplasm Proteins/metabolism | 2 | 0.0 |
Antigens, CD19 | 2 | 1.0 |
Multigene Family/genetics | 2 | 1.0 |
Reflex/*physiology | 2 | 8.0 |
Remission Induction | 3 | 0.0 |
Caspases/*metabolism | 2 | 0.0 |
Homeostasis | 2 | 0.0 |
Gene Amplification | 3 | 0.0 |
DNA/analysis | 6 | 0.0 |
DNA/metabolism | 2 | 0.0 |
*Introns | 4 | 1.0 |
*Platelet Count | 2 | 6.0 |
RNA, Messenger/*analysis/genetics | 2 | 4.0 |
Fusion Proteins, bcr-abl/analysis | 2 | 22.0 |
*Mutation | 3 | 0.0 |
*DNA Damage | 2 | 0.0 |
Brain/*metabolism | 2 | 0.0 |
Deoxyribonucleases, Type II Site-Specific | 4 | 1.0 |
Chromosomes, Human, Pair 22/ultrastructure | 2 | 66.0 |
Chromosomes, Human, Pair 9/*ultrastructure | 2 | 33.0 |
Leukemia, Myeloid, Chronic/genetics/*pathology | 4 | 30.0 |
DNA/genetics | 8 | 0.0 |
Protein p53/*metabolism | 2 | 0.0 |
DNA | 3 | 0.0 |
Proteins/*genetics/metabolism | 2 | 0.0 |
Oligodeoxyribonucleotides | 3 | 0.0 |
gamma-Glutamyltransferase/*genetics | 3 | 33.0 |
Blast Crisis/genetics | 5 | 26.0 |
Fusion Proteins, bcr-abl/*analysis | 4 | 66.0 |
RNA, Neoplasm/*genetics | 2 | 11.0 |
Leukemia, Lymphocytic, Acute/*genetics | 3 | 3.0 |
Guanosine Diphosphate/metabolism | 2 | 1.0 |
*Hematopoiesis | 2 | 1.0 |
In Situ Hybridization | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
DNA Probes | 9 | 0.0 |
Penis/innervation/physiopathology | 2 | 100.0 |
Leukemia, Myeloid, Philadelphia-Negative/genetics | 2 | 100.0 |
*Polymorphism, Restriction Fragment Length | 5 | 0.0 |
Protein-Tyrosine Kinase/*antagonists & inhibitors | 3 | 1.0 |
Chimerin 1 | 2 | 40.0 |
Proto-Oncogene Proteins/genetics/*physiology | 2 | 2.0 |
DNA/*analysis | 2 | 0.0 |
Receptors, Tumor Necrosis Factor/immunology | 3 | 13.0 |
Receptors, Tumor Necrosis Factor/*metabolism | 2 | 0.0 |
*Multigene Family | 5 | 0.0 |
Genes, Structural | 2 | 0.0 |
DNA/*genetics | 2 | 0.0 |
TATA Box | 2 | 0.0 |
Gene Frequency | 3 | 0.0 |
RNA/analysis | 2 | 0.0 |
Cell Adhesion | 2 | 0.0 |
Chromosomes, Human, Pair 22/*ultrastructure | 2 | 25.0 |
DNA Restriction Enzymes | 7 | 1.0 |
DNA, Neoplasm/*genetics | 2 | 0.0 |
Cell Survival/immunology | 2 | 3.0 |
*Genetic Markers | 3 | 0.0 |
Amino Acids/analysis | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Blast Crisis/*pathology | 2 | 11.0 |
Leukemia, Myeloid, Chronic/*genetics/mortality/pathology | 2 | 66.0 |
*Chromosome Deletion | 3 | 0.0 |
*Cloning, Molecular | 2 | 0.0 |
Fusion Proteins, bcr-abl | 5 | 45.0 |
Pedigree | 2 | 0.0 |
Mitogen-Activated Protein Kinases/physiology | 2 | 1.0 |
Neoplasm Proteins/*genetics | 2 | 0.0 |
Leukemia, Lymphocytic/*genetics | 7 | 35.0 |
Leukemia, Myeloid/genetics | 3 | 8.0 |
In Situ Nick-End Labeling | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Calcineurin/metabolism | 2 | 8.0 |
Gene Expression Regulation, Viral | 2 | 0.0 |
Antigens, CD19/physiology | 2 | 28.0 |
Cell Differentiation/*immunology | 3 | 11.0 |
Gene Expression Regulation, Neoplastic/*physiology | 2 | 1.0 |
Clone Cells/immunology/pathology | 2 | 15.0 |
Cytochrome c Group/metabolism | 2 | 1.0 |
